DNAPrint Genomics, Inc. Stock OTC Bulletin Board
Equities
DNAG
US23324Q2021
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Financials (USD)
Sales 2005 | 1.28M | Sales 2006 | 2.43M | Capitalization | 3.79M |
---|---|---|---|---|---|
Net income 2005 | -8M | Net income 2006 | -12M | EV / Sales 2005 | 1.89 x |
Net cash position 2005 | 737K | Net cash position 2006 | 1.21M | EV / Sales 2006 | 1.06 x |
P/E ratio 2005 |
-0.23
x | P/E ratio 2006 |
-0.27
x | Employees | - |
Yield 2005 * |
-
| Yield 2006 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Monica Tamborini
DFI | Director of Finance/CFO | - | - |
1st Jan change | Capi. | |
---|---|---|
-1.99% | 41.35B | |
+42.15% | 40.38B | |
+1.95% | 39.05B | |
-14.19% | 26.67B | |
+1.52% | 24.07B | |
-24.06% | 18.36B | |
-4.13% | 11.68B | |
+20.79% | 11.6B | |
+6.91% | 11.15B |
- Stock Market
- Equities
- DNAG Stock
- DNAG Stock